[mirtazapine]- Serotonin-potentiating non-SSRIs, such as venlafaxine, nefazodone, trazodone and mirtazapine, have been evaluated in PTSD only in open-label and case studies..[Gregory:2004]{Human,Guideline}
[predominantly]- Bupropion (amfebutamone), a predominantly noradrenergic reuptake inhibitor, was ineffective in PTSD in an open-label study..[Gregory:2004]{Human,Guideline}
[disorder]- Post-traumatic stress disorder (PTSD) is a highly prevalent (7.8% lifetime rate) anxiety disorder with impairment in daily functioning, frequent suicidal behaviour and high rates of co-morbidity..[Gregory:2004]{Human,Guideline}
[used]- They should be avoided or used only short term because of potential depressogenic effects, and the possibility that they may promote or worsen PTSD..[Gregory:2004]{Human,Guideline}
|
| - Post-traumatic stress disorder (PTSD) is a highly prevalent (7.8% lifetime rate) anxiety disorder with impairment in daily functioning, frequent suicidal behaviour and high rates of co-morbidity..[Gregory:2004]{Human,Guideline}
- Serotonin-potentiating non-SSRIs, such as venlafaxine, nefazodone, trazodone and mirtazapine, have been evaluated in PTSD only in open-label and case studies..[Gregory:2004]{Human,Guideline}
- Bupropion (amfebutamone), a predominantly noradrenergic reuptake inhibitor, was ineffective in PTSD in an open-label study..[Gregory:2004]{Human,Guideline}
- They should be avoided or used only short term because of potential depressogenic effects, and the possibility that they may promote or worsen PTSD..[Gregory:2004]{Human,Guideline}
|
| [(Other)]:1.001358E-5
- Post-traumatic stress disorder (PTSD) is a highly prevalent (7.8% lifetime rate) anxiety disorder with impairment in daily functioning, frequent suicidal behaviour and high rates of co-morbidity..[Gregory:2004]{Human,Guideline}
- Serotonin-potentiating non-SSRIs, such as venlafaxine, nefazodone, trazodone and mirtazapine, have been evaluated in PTSD only in open-label and case studies..[Gregory:2004]{Human,Guideline}
|
|
|